Delighted to share our work on fixed-dose (polypill💊) therapy in the American Journal of Preventive Medicine (AJPM) 👇👇

authors.elsevier.com/c/1f7Cp2gOwG8R…

Grateful for @Shoukmed's leadership and Malak Munir's great work.

Blessed to have the guidance of Drs Steven Nissen, Samir Kapadia Erin D. Michos, M.D. Amgad Mentias, M.D., M.S., FACC FESC.

🚨SECURE TRIAL now on NEJM! Polypill better than usual care in secondary prevention after MI! Spanish Investigation on top of European Society of Cardiology 🇪🇸 Congrats Dr Castellano CNIC and thnks for the opportunity to collaborate Soc Esp Cardiología Asociación Cardiología Clínica SEC Alberto Cordero Borja Ibanez

#ESCCongress Day 1 Hot Lines 🔥

🫀TIME ➡️ 🌞 vs 🌚 anti HT 💊 is similar for ⬇️ MI, stroke and CV 💀

🫀SECURE ➡️ Polypill (ASA+statin+ramipril) is better than usual strategy for ⬇️ MI, stroke, CV 💀,urgent revasc.

🫀PERSPECTIVE➡️ ARNI vs ARB similar for cognitive dysfunction

After seeing first-hand how hard it is for patients and family members to manage optimal drug therapy after an #MI , which is usually concomitant with multiple other comorbidities, the results of the #polypill have me stoked!
#ESCCongress

SECURE study: treatment strategy based on a polypill containing aspirin, atorvastatin, and ramipril is safe, led to fewer recurrent CV events after MI #ESCCongress

SECURE trial presented by Fuster V / polypill ASS/ATORVA/RAMIPRIL reach superiority over usual Care! 👏👏
#ESCCongress Sociedad Argentina de Cardiología SIAC

#ESCCongress #lbt with TCTMD first up #SECURE polypill following recent AMI tctmd.com/news/polypill-… Erin D. Michos, M.D. Dr Anastasia Mihailidou FAHA FCSANZ FESC Alexandra Frogoudaki Professor Vijay Kunadian Harriette Van Spall, MD MPH Aaysha Cader Michael O'Riordan Shelley Zieroth Shelley Wood (she/her) Jolanta SillerMatula, MD PhD chief Erik Rafflenbeul

#SECURE trial: polypill containing aspirin, atorvastatin and ramipril leads to clinically relevant reductions in recurrent #cardiovascular events in post-myocardial infarction patients.

#ESCCongress

1.2/ A polypill strategy in secondary prevention: The #SECURE trial

📕🔗:
nejm.org/doi/pdf/10.105…
On-demand ESC 📺: bit.ly/3AQuvkB

#ESCcongress

6) Treatment with a polypill containing aspirin, ramipril and atorvastatin after MI resulted in a significantly decreased risk of major adverse events than usual care

Evidence: SECURE
nejm.org/doi/pdf/10.105…
#ESCCongress

🔥 #SECURE Trial, polypill vs usual care ✅polypill is non inferior and superior to usual care in sec. Prevention #esccongress2022 SABOURETCardiologist European Society of Cardiology Turkish Society of Cardiology Oktay Gülcü ,MD t.ozan🦅🐈👶🏻 I.H.Tanboga, MD, PhD Eralp Tutar Javier Escaned Süleyman Çağan Efe Göksel Çinier Prof Dr Muzaffer Degertekin Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

📌 #SECURE polypill as a strategy at the heart of secondary prevention 🎯

#CardioEd #CardioTwitter

Review: exercise 🏋️‍♀️🏃‍♀️is a non-pharmacological polypill 💊 for patients with certain comorbidities and can be used to treat:
-obesity
-type 2 diabetes
-cardiovascular disease 🫀
-aging-related muscle atrophy
-certain cancers
sciencedirect.com/science/articl…

Exercise is the Real Polypill

journals.physiology.org/doi/full/10.11…

True then, true now 👇

SECURE trial result polypill improves post IMA outcomes. Proud of being part this team thanks to Prof #Colivicchi for involving me! Congratulations to Prof #Fuster JM #Castellano CNIC Silvia Castelletti Felice Gragnano Nunzia Borrelli Italo Kumamoto

nejm.org/doi/full/10.10…

#Polypill reduces #cardiovascular events in #HeartAttack patients compared to usual care escardio.org/The-ESC/Press-…

#ESCCongress #PharmacoTherapy

Review: exercise 🏋️‍♀️ sustains the major hallmarks of health, is considered a non-pharmacological ”polypill” 💊 for patients with comorbidities and is a protective strategy to maintain health in response to stress: sciencedirect.com/science/articl…

Treatment with a polypill containing aspirin, ramipril, and atorvastatin within 6 months after myocardial infarction resulted in a significantly lower risk of major adverse cardiovascular events than usual care!

NEJM

nejm.org/doi/full/10.10…

Benefits of polypill in secondary prevention of CVD.
#CVCT 2022 #CVCT

CVCT - CardioVascular Clinical Trialists Anju Bhardwaj MD FACC Carlos G Santos-Gallego, MD Rachna Kataria, MD Faiez ZANNAD Dr.Rajiv Sankaranarayanan

Polypill Strategy in Secondary Cardiovascular Prevention : #SECURE trial has been now published in NEJM

nejm.org/doi/full/10.10…

#ESCCongress Dr. Deepak L. Bhatt #GDMT #ESCCongress Lavinia Baciu Stephan Achenbach JACC Journals #JACC Gregg Fonarow MD Less-Is-More Cardiologist